annual total liabilities:
$332.34M-$23.82M(-6.69%)Summary
- As of today (May 29, 2025), SUPN annual total liabilities is $332.34 million, with the most recent change of -$23.82 million (-6.69%) on December 31, 2024.
- During the last 3 years, SUPN annual total liabilities has fallen by -$540.96 million (-61.94%).
- SUPN annual total liabilities is now -61.94% below its all-time high of $873.30 million, reached on December 31, 2021.
Performance
SUPN Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$316.58M-$15.76M(-4.74%)Summary
- As of today (May 29, 2025), SUPN quarterly total liabilities is $316.58 million, with the most recent change of -$15.76 million (-4.74%) on March 31, 2025.
- Over the past year, SUPN quarterly total liabilities has dropped by -$58.34 million (-15.56%).
- SUPN quarterly total liabilities is now -64.01% below its all-time high of $879.66 million, reached on March 31, 2023.
Performance
SUPN quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SUPN Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.7% | -15.6% |
| 3 y3 years | -61.9% | -61.0% |
| 5 y5 years | -41.2% | -45.1% |
SUPN Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -61.9% | at low | -64.0% | at low |
| 5 y | 5-year | -61.9% | at low | -64.0% | at low |
| alltime | all time | -61.9% | +812.5% | -64.0% | +769.3% |
SUPN Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $316.58M(-4.7%) |
| Dec 2024 | $332.34M(-6.7%) | $332.34M(-1.0%) |
| Sep 2024 | - | $335.55M(-6.4%) |
| Jun 2024 | - | $358.38M(-4.4%) |
| Mar 2024 | - | $374.92M(+5.3%) |
| Dec 2023 | $356.16M(-56.4%) | $356.16M(-4.5%) |
| Sep 2023 | - | $372.97M(-0.1%) |
| Jun 2023 | - | $373.19M(-57.6%) |
| Mar 2023 | - | $879.66M(+7.8%) |
| Dec 2022 | $816.30M(-6.5%) | $816.30M(-2.9%) |
| Sep 2022 | - | $840.33M(-1.5%) |
| Jun 2022 | - | $853.54M(+5.2%) |
| Mar 2022 | - | $811.07M(-7.1%) |
| Dec 2021 | $873.30M(+15.0%) | $873.30M(+17.3%) |
| Sep 2021 | - | $744.57M(-5.4%) |
| Jun 2021 | - | $787.48M(+4.6%) |
| Mar 2021 | - | $753.00M(-0.8%) |
| Dec 2020 | $759.24M(+34.4%) | $759.24M(-5.2%) |
| Sep 2020 | - | $801.14M(-2.9%) |
| Jun 2020 | - | $825.05M(+43.1%) |
| Mar 2020 | - | $576.48M(+2.1%) |
| Dec 2019 | $564.85M(+7.6%) | $564.85M(+2.8%) |
| Sep 2019 | - | $549.65M(+1.6%) |
| Jun 2019 | - | $540.77M(-0.9%) |
| Mar 2019 | - | $545.43M(+3.9%) |
| Dec 2018 | $524.79M(+234.3%) | $524.79M(+4.8%) |
| Sep 2018 | - | $500.58M(+8.3%) |
| Jun 2018 | - | $462.31M(-2.3%) |
| Mar 2018 | - | $473.29M(+201.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $156.98M(+33.2%) | $156.98M(+17.3%) |
| Sep 2017 | - | $133.81M(+14.4%) |
| Jun 2017 | - | $116.97M(+0.7%) |
| Mar 2017 | - | $116.19M(-1.4%) |
| Dec 2016 | $117.81M(+17.1%) | $117.81M(+5.4%) |
| Sep 2016 | - | $111.75M(+44.0%) |
| Jun 2016 | - | $77.61M(+17.0%) |
| Mar 2016 | - | $66.33M(-34.1%) |
| Dec 2015 | $100.62M(+4.7%) | $100.62M(+75.5%) |
| Sep 2015 | - | $57.33M(+10.7%) |
| Jun 2015 | - | $51.80M(+15.0%) |
| Mar 2015 | - | $45.05M(-53.1%) |
| Dec 2014 | $96.08M(+23.9%) | $96.08M(+59.6%) |
| Sep 2014 | - | $60.21M(-1.0%) |
| Jun 2014 | - | $60.82M(-11.2%) |
| Mar 2014 | - | $68.51M(-11.6%) |
| Dec 2013 | $77.53M(+112.9%) | $77.53M(-30.3%) |
| Sep 2013 | - | $111.31M(+15.9%) |
| Jun 2013 | - | $96.08M(+154.3%) |
| Mar 2013 | - | $37.79M(+3.8%) |
| Dec 2012 | $36.42M(-17.8%) | $36.42M(-14.1%) |
| Sep 2012 | - | $42.38M(+0.9%) |
| Jun 2012 | - | $41.98M(-2.2%) |
| Mar 2012 | - | $42.93M(-3.1%) |
| Dec 2011 | $44.29M(-51.5%) | $44.29M(-57.8%) |
| Sep 2011 | - | $104.83M(+14.8%) |
| Dec 2010 | $91.33M(+6.1%) | $91.33M(-2.2%) |
| Sep 2010 | - | $93.42M(+8.6%) |
| Dec 2009 | $86.06M(+2.6%) | $86.06M |
| Dec 2008 | $83.88M | - |
FAQ
- What is Supernus Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual total liabilities year-on-year change?
- What is Supernus Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly total liabilities year-on-year change?
What is Supernus Pharmaceuticals annual total liabilities?
The current annual total liabilities of SUPN is $332.34M
What is the all time high annual total liabilities for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual total liabilities is $873.30M
What is Supernus Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, SUPN annual total liabilities has changed by -$23.82M (-6.69%)
What is Supernus Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of SUPN is $316.58M
What is the all time high quarterly total liabilities for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly total liabilities is $879.66M
What is Supernus Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, SUPN quarterly total liabilities has changed by -$58.34M (-15.56%)